Alexandria Investors Face Jan. 26 Deadline to Seek Lead in Securities Suit Over LIC Impairment
Plaintiffs allege Alexandria misled investors about the Long Island City site's life‑science prospects following a $323.9 million write‑down.
Overview
- The case, Hern v. Alexandria Real Estate Equities, Inc., No. 2:25-cv-11319, is pending in the U.S. District Court for the Central District of California under Sections 10(b) and 20(a).
- Investors who bought shares between January 27, 2025 and October 27, 2025 have until January 26, 2026 to move for lead‑plaintiff status.
- The complaint claims the company overstated leasing strength, occupancy stability, and its tenant pipeline while misrepresenting the Long Island City property's life‑science value.
- On October 27, 2025 the company missed Q3 expectations, cut guidance, recorded a $323.9 million impairment with $206 million tied to the LIC asset, and flagged potential additional Q4 impairments up to $685 million.
- The stock fell $14.93, or more than 19%, by October 28, 2025, and multiple firms including Bleichmar Fonti & Auld, Rosen Law Firm, and the Law Offices of Howard G. Smith are soliciting investors on a contingency basis with no class yet certified.